UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Randomized, Placebo-Controlled Phase II Study Evaluating the Reduction of Neutropenia and Febrile Neutropenia in Patients With Colorectal Cancer Receiving Pegfilgrastim With Every-2-Week Chemotherapy

Clinical colorectal cancer, 2010-04, Vol.9 (2), p.95-101

2010

Volltextzugriff (PDF)

Immunotyping of lymphoma by fine-needle aspiration : a comparative study of cytospin preparations and flow cytometry

American journal of clinical pathology, 1994-05, Vol.101 (5), p.569-576

1994

Volltextzugriff (PDF)

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

Journal of clinical oncology, 1992-05, Vol.10 (5), p.790-794

1992

Volltextzugriff (PDF)

Small Noncleaved Cell Lymphoma in Adults Superior Results for Stages I–III Disease

Journal of clinical oncology, 1994-03, Vol.12 (3), p.646-646

1994

Volltextzugriff (PDF)

Effective Salvage Therapy for Lymphoma With Cisplatin in Combination With High-Dose Ara-C and Dexamethasone (DHAP)

Blood, 1988-01, Vol.71 (1), p.117-122

1988

Volltextzugriff (PDF)

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma

Journal of clinical oncology, 1994-03, Vol.12 (3), p.575-579

1994

Volltextzugriff (PDF)

Radiotherapy during pregnancy for clinical stages IA–IIA Hodgkin's disease

International journal of radiation oncology, biology, physics, 1992, Vol.23 (2), p.407-412

1992

Volltextzugriff (PDF)

Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma

Journal of clinical oncology, 1995-03, Vol.13 (3), p.583-587

1995

Volltextzugriff (PDF)

Significance of tumor size and radiation dose to local control in Stage I–III diffuse large cell lymphoma treated with CHOP-Bleo and radiation

International journal of radiation oncology, biology, physics, 1995, Vol.31 (1), p.3-11

1995

Volltextzugriff (PDF)

Prognostic value of serum beta-2 microglobulin in low-grade lymphoma

Annals of internal medicine, 1991-05, Vol.114 (10), p.855-860

1991

Volltextzugriff (PDF)

No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule

Journal of clinical oncology, 1996-02, Vol.14 (2), p.543-548

1996

Volltextzugriff (PDF)

Prognostic role of serum β2-microglobulin in Hodgkin's disease

Journal of clinical oncology, 1993, Vol.11 (6), p.1108-1111

1993

Volltextzugriff (PDF)

Risk Classification as the Basis for Clinical Staging of Diffuse Large-Cell Lymphoma Derived From 10-Year Survival Data

Blood, 1989-08, Vol.74 (2), p.551-557

1989

Volltextzugriff (PDF)

Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse

Journal of clinical oncology, 1991-02, Vol.9 (2), p.236-242

1991

Volltextzugriff (PDF)

Small noncleaved cell lymphoma in adults: superior results for stages I-III disease

Journal of clinical oncology, 1990-04, Vol.8 (4), p.615-622

1990

Volltextzugriff (PDF)

Intermediate‐grade lymphomas treated with cyclophosphamide‐doxorubicin‐vincristine‐prednisone‐bleomycin alternated with cyclophosphamide‐methotrexate‐etoposide‐dexamethasone. Application of prognostic models to data analysis

Cancer, 1994-05, Vol.73 (9), p.2408-2416

1994

Volltextzugriff (PDF)

Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma

The American journal of medicine, 1989-08, Vol.87 (2), p.167-172

1989

Volltextzugriff (PDF)

Risk Classification for Large Cell Lymphoma using Lactate Dehydrogenase, Beta-2 Microglobulin, and Thymidine Kinase

Leukemia & lymphoma, 1995, Vol.18 (1-2), p.87-92

1995

Volltextzugriff (PDF)

Relationship between DNA ploidy level, nuclear size, and survival in large cell lymphoma

American journal of clinical pathology, 1995-05, Vol.103 (5), p.568-573

1995

Volltextzugriff (PDF)

Stages I and II Diffuse Large Cell Lymphomas: Prognostic Factors and Long-Term Results With CHOP-Bleo and Radiotherapy

Blood, 1991-03, Vol.77 (5), p.942-947

1991

Volltextzugriff (PDF)

Recent trends in the management of lymphomas at M.D. Anderson Cancer Center

Seminars in oncology, 1990-12, Vol.17 (6 Suppl 10), p.28-32; discussion 32-3

1990

Volltextzugriff (PDF)

NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease

Seminars in oncology, 1990-12, Vol.17 (6 Suppl 10), p.34

1990

Volltextzugriff (PDF)

High dose cyclophosphamide, BCNU, and VP‐16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemia

Cancer, 1987-03, Vol.59 (6), p.1083-1086

1987

Volltextzugriff (PDF)

Detection of residual leukemic cells in remission bone marrow by interleukin-2 (IL 2) expanded autologous lymphocytes

Leukemia research, 1986, Vol.10 (1), p.102-102

1986

Volltextzugriff (PDF)

A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas

Investigational new drugs, 1994-01, Vol.12 (3), p.217-222

1994

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Biological And Medical Sciences
(17)
Female
(17)
Male
(17)
Medical Sciences
(17)
Middle Aged
(16)
Adult
(15)
Oncology
(14)
Aged
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Antineoplastic Agents
(9)
Pharmacology. Drug Treatments
(9)
Chemotherapy
(8)
Combined Modality Therapy
(8)
Prognosis
(8)
Remission Induction
(8)
Neoplasm Staging
(7)
Adolescent
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Randomized, Placebo-Controlled Phase II Study Evaluating the Reduction of Neutropenia and Febrile Neutropenia in Patients With Colorectal Cancer Receiving Pegfilgrastim With Every-2-Week Chemotherapy

Immunotyping of lymphoma by fine-needle aspiration : a comparative study of cytospin preparations and flow cytometry

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

Small Noncleaved Cell Lymphoma in Adults Superior Results for Stages I–III Disease

Effective Salvage Therapy for Lymphoma With Cisplatin in Combination With High-Dose Ara-C and Dexamethasone (DHAP)

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma

Radiotherapy during pregnancy for clinical stages IA–IIA Hodgkin's disease

Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma

Significance of tumor size and radiation dose to local control in Stage I–III diffuse large cell lymphoma treated with CHOP-Bleo and radiation

Prognostic value of serum beta-2 microglobulin in low-grade lymphoma

No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule

Prognostic role of serum β2-microglobulin in Hodgkin's disease

Risk Classification as the Basis for Clinical Staging of Diffuse Large-Cell Lymphoma Derived From 10-Year Survival Data

Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse

Small noncleaved cell lymphoma in adults: superior results for stages I-III disease

Intermediate‐grade lymphomas treated with cyclophosphamide‐doxorubicin‐vincristine‐prednisone‐bleomycin alternated with cyclophosphamide‐methotrexate‐etoposide‐dexamethasone. Application of prognostic models to data analysis

Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma

Risk Classification for Large Cell Lymphoma using Lactate Dehydrogenase, Beta-2 Microglobulin, and Thymidine Kinase

Relationship between DNA ploidy level, nuclear size, and survival in large cell lymphoma

Stages I and II Diffuse Large Cell Lymphomas: Prognostic Factors and Long-Term Results With CHOP-Bleo and Radiotherapy

Recent trends in the management of lymphomas at M.D. Anderson Cancer Center

NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease

High dose cyclophosphamide, BCNU, and VP‐16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemia

Detection of residual leukemic cells in remission bone marrow by interleukin-2 (IL 2) expanded autologous lymphocytes

A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas

Suchergebnisse filtern